FDA
-
-
-
-
-
-
-
TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call
-
-
-
-
-
-
-
TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance
-
-
-
-
-
-
-
TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors
-
-
-
-
-
-
-
TriSalus publishes thyroid embolization study results
-
-
-
-
-
-
-
TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
-
-
-
-
-
-
-
TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call
-
-
-
-
-
-
-
TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
-
324,764 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

